![Expanding insights of mitochondrial dysfunction in Parkinson's disease | Nature Reviews Neuroscience Expanding insights of mitochondrial dysfunction in Parkinson's disease | Nature Reviews Neuroscience](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrn1868/MediaObjects/41583_2006_Article_BFnrn1868_Fig3_HTML.jpg)
Expanding insights of mitochondrial dysfunction in Parkinson's disease | Nature Reviews Neuroscience
![Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrn3549/MediaObjects/41583_2013_Article_BFnrn3549_Fig1_HTML.jpg)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience
![Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor | npj Parkinson's Disease Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-021-00179-6/MediaObjects/41531_2021_179_Fig1_HTML.png)
Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor | npj Parkinson's Disease
![Emerging therapies in Parkinson disease — repurposed drugs and new approaches | Nature Reviews Neurology Emerging therapies in Parkinson disease — repurposed drugs and new approaches | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-019-0155-7/MediaObjects/41582_2019_155_Fig1_HTML.png)
Emerging therapies in Parkinson disease — repurposed drugs and new approaches | Nature Reviews Neurology
![Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms](https://pub.mdpi-res.com/biology/biology-09-00103/article_deploy/html/images/biology-09-00103-g001.png?1589890467)
Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms
![Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrn983/MediaObjects/41583_2002_Article_BFnrn983_Fig1_HTML.jpg)
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience
![Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrn983/MediaObjects/41583_2002_Article_BFnrn983_Fig2_HTML.jpg)
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience
![Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? | Nature Reviews Neuroscience Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41583-021-00542-9/MediaObjects/41583_2021_542_Fig1_HTML.png)